From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
CEPC structure.png
  • 6-Chloro-5-ethoxy-N-(pyridin-2-yl)indoline-1-carboxamide
CAS Number
  • 1384929-25-2
PubChem CID
Chemical and physical data
Molar mass317.77 g·mol−1
3D model (JSmol)
  • c3cccnc3NC(=O)N(c1cc2Cl)CCc1cc2OCC

6-Chloro-5-ethoxy-N-(pyridin-2-yl)indoline-1-carboxamide (CEPC) is a drug which acts as a potent and selective antagonist for the serotonin 5-HT2C receptor. In animal studies it was found to potentiate the conditioned place preference induced by low-dose amphetamine, demonstrating that 5-HT2C-mediated disinhibition of dopamine release can cause interactions with dopaminergic drugs.[1]

See also[edit]


  1. ^ McCorvy JD, Harland AA, Maglathlin R, Nichols DE (November 2011). "A 5-HT(2C) receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference". Neuroscience Letters. 505 (1): 10–3. doi:10.1016/j.neulet.2011.07.036. PMC 3213641. PMID 21827831.